GB2111990B - Cepham derivatives - Google Patents

Cepham derivatives

Info

Publication number
GB2111990B
GB2111990B GB08235480A GB8235480A GB2111990B GB 2111990 B GB2111990 B GB 2111990B GB 08235480 A GB08235480 A GB 08235480A GB 8235480 A GB8235480 A GB 8235480A GB 2111990 B GB2111990 B GB 2111990B
Authority
GB
United Kingdom
Prior art keywords
cepham derivatives
cepham
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08235480A
Other languages
English (en)
Other versions
GB2111990A (en
Inventor
Stjepan Kukolja
Janice Lucile Pfeil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/333,156 external-priority patent/US4431803A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB2111990A publication Critical patent/GB2111990A/en
Application granted granted Critical
Publication of GB2111990B publication Critical patent/GB2111990B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08235480A 1981-12-21 1982-12-13 Cepham derivatives Expired GB2111990B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33315481A 1981-12-21 1981-12-21
US06/333,156 US4431803A (en) 1981-12-21 1981-12-21 7-Epi 3-exomethylenecephams

Publications (2)

Publication Number Publication Date
GB2111990A GB2111990A (en) 1983-07-13
GB2111990B true GB2111990B (en) 1985-07-24

Family

ID=26988581

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08235480A Expired GB2111990B (en) 1981-12-21 1982-12-13 Cepham derivatives

Country Status (7)

Country Link
EP (1) EP0082656A3 (cg-RX-API-DMAC10.html)
KR (1) KR860001364B1 (cg-RX-API-DMAC10.html)
CA (1) CA1200543A (cg-RX-API-DMAC10.html)
DK (1) DK557682A (cg-RX-API-DMAC10.html)
GB (1) GB2111990B (cg-RX-API-DMAC10.html)
GR (1) GR77832B (cg-RX-API-DMAC10.html)
HU (1) HU189206B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587053A (en) * 1984-04-26 1986-05-06 Eli Lilly And Company Preparation of oxazolines
US5571910A (en) * 1994-12-09 1996-11-05 Schering Corporation Process for the preparation of intermediates useful in the synthesis of cephalosporins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308292A (cg-RX-API-DMAC10.html) * 1972-06-30 1974-01-02
CA1022542A (en) * 1973-01-09 1977-12-13 Bruno Fechtig Process for the manufacture of methylene compounds

Also Published As

Publication number Publication date
EP0082656A3 (en) 1984-09-12
CA1200543A (en) 1986-02-11
KR840002841A (ko) 1984-07-21
EP0082656A2 (en) 1983-06-29
KR860001364B1 (ko) 1986-09-16
GB2111990A (en) 1983-07-13
HU189206B (en) 1986-06-30
GR77832B (cg-RX-API-DMAC10.html) 1984-09-25
DK557682A (da) 1983-06-22

Similar Documents

Publication Publication Date Title
GB2144424B (en) Cephem derivatives
GB8417905D0 (en) Hydroxymethyl-5 oxazolidinic derivatives
GB2111483B (en) 3-acylamino-4-hydroxy-phenethylamine derivatives
GB2101986B (en) Thiazolinoazetidinone derivatives
GB2155932B (en) Phenylhydrazinomethylenemalononitrile derivatives
GB2099424B (en) Isoprenylamine derivatives
GB2099419B (en) Imidazothizole derivatives
GB2094297B (en) Apovincaminol derivatives
GB2099423B (en) Isopyrenylamine derivatives
GB2098613B (en) Polyisoprenylamine derivatives
GB2102423B (en) Cephalosporin derivatives
GB2111990B (en) Cepham derivatives
GB2112781B (en) Aminopropylaminobleomycin derivatives
JPS57123191A (en) Novel cephalosporin derivatives
DE3270774D1 (en) Cephalosporin derivatives
ZA82859B (en) Cephalosporin derivatives
EP0066144A3 (en) Benzylazole derivatives
DE3272020D1 (en) Cephalosporin derivatives
GB2102424B (en) Cephalosporin derivatives
DE3271892D1 (en) Cephalosporin derivatives
ZW22181A1 (en) Cephalosporin derivatives
GB2106908B (en) Alkoxyvincamone derivatives
GB2108105B (en) Isoprenylamine derivatives
GB2100728B (en) 3-substituted -2- cyclopentenone derivatives
ZA826815B (en) Cephalosporin derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee